Tech Company Financing Transactions

OrphoMed Funding Round

OrphoMed, based in San Francisco, raised $39 million in investment from New Enterprise Associates, Takeda Ventures and Mario Family Fund.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

50 Francisco St. 245
San Francisco, CA 94133
USA

Phone

(415) 569-4417

Website

www.orphomed.com

Email Address

[email protected]

Overview

OrphoMed is a San Francisco Bay Area pharmaceutical company focused on the development of novel first-in-class therapeutic dimer conjugates based on its proprietary DIMERx platform technology.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gary Phillips

        

Chief Scientific Officer

Nikhilesh Singh

        

Vice President

Virginia Sanders

        

Vice President

Lisa Turner

        

VP - Finance

Gregory Beyer

        

VP - Regulatory Affairs

Michelle Usher

        

Browse more venture capital transactions:

Prev: 5/25/2017: Chromatin venture capital transaction
Next: 5/25/2017: TruTouch Technologies venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary